Your search returned 48 studies. (Get alerts for new studies):
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
209 Locations available
- Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Perito
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
245 Locations available
- Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinu
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
Conditions: Ovarian Cancer
1 Location available
- Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
Conditions: Ovarian Neoplasms
14 Locations available
- Exhaled Breath Biomarkers in Finding Ovarian Epithelial Cancer in Patients With Newly Diagnosed Ovarian Epithelial Cancer, Polycystic Ovarian Syndrome
Conditions: Ovarian Cancer
4 Locations available
- A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ova
Conditions: Cancer - Carcinoma - Fallopian Tube Cancer - Gynecological Malignancies - Metastases - Oncology - Ovarian Cancer - Solid Tumors - Tumors
8 Locations available
- OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
29 Locations available
- Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
23 Locations available
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tum
Conditions: Solid Tumors - Ovarian Cancer
7 Locations available
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
98 Locations available
- Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
2 Locations available
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
16 Locations available
- Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial
Conditions: Endometrial Cancer - Gastrointestinal Carcinoid Tumor - Islet Cell Tumor - Liver Cancer - Lung Cancer - Ovarian Cancer
6 Locations available
- ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Per
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
30 Locations available
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
7 Locations available
- Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemothera
Conditions: Epithelial Ovarian Cancer
1 Location available
- Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Conditions: Ovarian Cancer
1 Location available
- First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, Peritoneal Cancer, or Recurrent T
Conditions: Breast Cancer - Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
22 Locations available
- EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
11 Locations available
- A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
Conditions: Epithelial Ovarian Cancer
4 Locations available
- N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
Conditions: Ovarian Carcinoma, Stage 3 or 4 - Epithelial Ovarian Carcinoma - Primary Peritoneal Carcinoma
1 Location available
- Neoadjuvant Therapy for Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
4 Locations available
- RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Changes in Performance Status and Symptom Distress in Older Patients With Advanced Ovarian Epithelial Cancer Undergoing Surgery and/or Chemotherapy
Conditions: Ovarian Cancer
1 Location available
- Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal C
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
5 Locations available
- SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cis
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Conditions: Ovarian Cancer - Epithelial Ovarian Cancer - Fallopian Tube Carcinoma - Primary Peritoneal Carcinoma
1 Location available
- Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remis
Conditions: Fallopian Tubes - Ovarian Cancer - Peritoneal Cancer
1 Location available
- Carboplatin, Pegylated Liposomal Doxorubicin Hydrochloride, and Everolimus in Treating Patients With Relapsed Ovarian Epithelial, Fallopian Tube, or P
Conditions: Fallopian Tube Cancer - Peritoneal Cavity Cancer - Recurrent Ovarian Epithelial Cancer
1 Location available
- VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal C
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
6 Locations available
- Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
8 Locations available
- Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavi
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
69 Locations available
- Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Conditions: Invasive Epithelial Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Vaccine Therapy in Treating Patients With Stage III-IV Ovarian Cancer
Conditions: Stage III Ovarian Epithelial Cancer - Stage III Ovarian Germ Cell Tumor - Stage IV Ovarian Epithelial Cancer - Stage IV Ovarian Germ Cell Tumor
1 Location available
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
97 Locations available
- Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
1 Location available
- A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
10 Locations available
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
78 Locations available
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
Conditions: Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cell Tumor - Malignant Tumor of Peritoneum - Stage IV Ovarian Epithelial Cancer - Stage IV Ovarian Germ Cell Tumor
1 Location available
- Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy
Conditions: Epithelial Ovarian Cancer
2 Locations available
- Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
27 Locations available
- Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand
Conditions: Epithelial Ovarian Cancer
2 Locations available
|